Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer
The intracellular serine/threonine interleukin 1 receptor-associated kinase 4 (IRAK4) is necessary for most signaling by activated Toll-like receptors (TLRs). Activation of IRAK4 drives activation of nuclear factor kappa B (NF-κB) and so promotes cell survival, inflammation, and other aspects of the...
Main Authors: | Guillermo Garcia-Manero, Uwe Platzbecker, Kian-Huat Lim, Grzegorz Nowakowski, Omar Abdel-Wahab, Hagop Kantarjian, Amit Verma, Daniel T. Starczynowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Hematology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/frhem.2024.1339870/full |
Similar Items
-
The IRAK-M death domain: a tale of three surfaces
by: Berke Gürkan, et al.
Published: (2024-01-01) -
Interleukin-1 receptor associated kinase 1 (IRAK1) is epigenetically activated in luminal epithelial cells in prostate cancer
by: Undraga Schagdarsurengin, et al.
Published: (2022-09-01) -
IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
by: Ricardo D. Parrondo, et al.
Published: (2023-10-01) -
Regulation of innate immune signaling by IRAK proteins
by: Milton Pereira, et al.
Published: (2023-02-01) -
The Alphaviral Capsid Protein Inhibits IRAK1-Dependent TLR Signaling
by: V. Douglas Landers, et al.
Published: (2021-02-01)